These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27280242)

  • 1. Modulation of Dendritic Cells by Nanotechnology-Based Immunotherapeutic Strategies.
    Mogrão J; da Costa CA; Gaspar R; Florindo HF
    J Biomed Nanotechnol; 2016 Mar; 12(3):405-34. PubMed ID: 27280242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
    Klippstein R; Pozo D
    Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells.
    Shen H; Sun T; Hoang HH; Burchfield JS; Hamilton GF; Mittendorf EA; Ferrari M
    Semin Immunol; 2017 Dec; 34():114-122. PubMed ID: 28947107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Part II: targeted particles for imaging of anticancer immune responses.
    Hung RW; Hamdy S; Haddadi A; Ghotbi Z; Lavasanifar A
    Curr Drug Deliv; 2011 May; 8(3):274-81. PubMed ID: 21291375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional nanoparticles for cancer immunotherapy.
    Saleh T; Shojaosadati SA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1863-75. PubMed ID: 26901287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in cancer immunotherapy.
    Gunzer M; Grabbe S
    Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.
    Pinho MP; Sundarasetty BS; Bergami-Santos PC; Steponavicius-Cruz K; Ferreira AK; Stripecke R; Barbuto JA
    Cytotherapy; 2016 Apr; 18(4):570-80. PubMed ID: 26971685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell preparation for immunotherapeutic interventions.
    Simon T; Fonteneau JF; Grégoire M
    Immunotherapy; 2009 Mar; 1(2):289-302. PubMed ID: 20635946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA pulsed dendritic cells: an approach for cancer immunotherapy.
    Garg NK; Dwivedi P; Prabha P; Tyagi RK
    Vaccine; 2013 Feb; 31(8):1141-56. PubMed ID: 23306369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune based therapies in cancer.
    Krüger C; Greten TF; Korangy F
    Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
    Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
    J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles for dendritic cell-based immunotherapy.
    Tran TH; Tran TTP; Nguyen HT; Phung CD; Jeong JH; Stenzel MH; Jin SG; Yong CS; Truong DH; Kim JO
    Int J Pharm; 2018 May; 542(1-2):253-265. PubMed ID: 29555438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.
    Klauber TCB; Laursen JM; Zucker D; Brix S; Jensen SS; Andresen TL
    Acta Biomater; 2017 Apr; 53():367-377. PubMed ID: 28153581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inorganic nanoparticles as potential regulators of immune response in dendritic cells.
    Fogli S; Montis C; Paccosi S; Silvano A; Michelucci E; Berti D; Bosi A; Parenti A; Romagnoli P
    Nanomedicine (Lond); 2017 Jul; 12(14):1647-1660. PubMed ID: 28635380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to improve dendritic cell-based immunotherapy against cancer.
    Song SY; Kim HS
    Yonsei Med J; 2004 Jun; 45 Suppl():48-52. PubMed ID: 15250050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-based cancer therapy.
    Conrad C; Nestle FO
    Curr Opin Mol Ther; 2003 Aug; 5(4):405-12. PubMed ID: 14513684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies.
    Sbiera S; Wortmann S; Fassnacht M
    Horm Metab Res; 2008 Feb; 40(2):89-98. PubMed ID: 18283626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.
    Bhargava A; Mishra D; Banerjee S; Mishra PK
    Immunotherapy; 2012 Jul; 4(7):703-18. PubMed ID: 22853757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.